Business Description
AP Biosciences Inc
ISIN : TW0006945009
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 22.75 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 26.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 187.3 | |||||
3-Year FCF Growth Rate | -987.4 | |||||
3-Year Book Growth Rate | 396.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.01 | |||||
9-Day RSI | 64.42 | |||||
14-Day RSI | 62.69 | |||||
6-1 Month Momentum % | -15.96 | |||||
12-1 Month Momentum % | -0.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 53.98 | |||||
Quick Ratio | 53.98 | |||||
Cash Ratio | 53.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -115.4 | |||||
Shareholder Yield % | -24.36 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1413.49 | |||||
Net Margin % | -1387.42 | |||||
FCF Margin % | -1321.57 | |||||
ROE % | -37.67 | |||||
ROA % | -34.6 | |||||
ROIC % | -353.61 | |||||
ROC (Joel Greenblatt) % | -402.02 | |||||
ROCE % | -35.27 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 114.07 | |||||
PB Ratio | 2.69 | |||||
Price-to-Tangible-Book | 2.7 | |||||
EV-to-EBIT | -7.07 | |||||
EV-to-EBITDA | -7.35 | |||||
EV-to-Revenue | 97.86 | |||||
EV-to-FCF | -7.62 | |||||
Price-to-Net-Current-Asset-Value | 2.89 | |||||
Price-to-Net-Cash | 2.94 | |||||
Earnings Yield (Greenblatt) % | -14.12 | |||||
FCF Yield % | -8.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AP Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 32.253 | ||
EPS (TTM) (NT$) | -6.87 | ||
Beta | 0 | ||
Volatility % | 32.77 | ||
14-Day RSI | 62.69 | ||
14-Day ATR (NT$) | 1.306583 | ||
20-Day SMA (NT$) | 53.99 | ||
12-1 Month Momentum % | -0.77 | ||
52-Week Range (NT$) | 41.05 - 70 | ||
Shares Outstanding (Mil) | 84.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AP Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AP Biosciences Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
AP Biosciences Inc Frequently Asked Questions
What is AP Biosciences Inc(ROCO:6945)'s stock price today?
When is next earnings date of AP Biosciences Inc(ROCO:6945)?
Does AP Biosciences Inc(ROCO:6945) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |